Anti-Androgen Receptor antibody [EPR1535(2)] (Ab133273)
DHTR, NR3C4, AR, Androgen receptor, Dihydrotestosterone receptor, Nuclear receptor subfamily 3 group C member 4
详细信息
背景信息
Anti-Androgen Receptor antibody [EPR1535(2)] (ab133273) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, WB in human, mouse, rat samples. Anti-Androgen Receptor antibody [EPR1535(2)] (ab133273) has been cited over 124 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Androgen Receptor antibody [EPR1535(2)] (ab133273) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Androgen Receptor antibody [EPR1535(2)] (ab133273) has 11 independent reviews from customers. Anti-Androgen Receptor antibody [EPR1535(2)] (ab133273) specifically detects Androgen Receptor (UniProt ID: P10275; Molecular weight: 99kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR1535(2) - ab271891. Antibody clone EPR1535(2) is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, HRP, Alexa Fluor® 555 ( ab194194, ab194195, ab194196, ab275124 ). The androgen receptor (AR)/DHTR plays a crucial role in the development and progression of various cancers, including breast cancer and prostate cancer. Utilizing our highly-validated AR antibody, can significantly enhance the detection and study of AR expression. Research indicates that AR is a promising therapeutic target for treating hormone-dependent cancers, offering potential for improved patient outcomes. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (169)
Ex Vivo Spatiotemporal Characterization of Spermatogenesis in Mouse Testicular Organoids.
小鼠睾丸类器官中精子发生的离体时空特征分析。
Dual regulation of CXCR6(+)CD8(+) T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression.
CXCR6(+)CD8(+) T 细胞的双重调控在前列腺癌进展过程中调节细胞毒性和耗竭相关程序。
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.
发现 BMS-986365,一种首创的双重雄激素受体配体导向降解剂和拮抗剂,用于治疗晚期前列腺癌。
KDM4A promotes NEPC progression through regulation of MYC expression.
KDM4A 通过调节 MYC 表达促进 NEPC 进展。
ERRγ impedes neuroendocrine prostate cancer development.
ERRγ 会阻碍神经内分泌前列腺癌的发展。
Testosterone Exposure During Fetal Masculinization Programming Window Determines the Kidney Size in Adult Mice.
胎儿雄性化编程窗口期睾酮暴露决定成年小鼠肾脏大小。
Luteolin alleviates PCOS by inhibiting AR/STAT3/NLRP3-mediated granulosa cell pyroptosis.
木犀草素通过抑制 AR/STAT3/NLRP3 介导的颗粒细胞焦亡来缓解多囊卵巢综合征。
Protocol for generating and characterizing Matrigel-free prostate cancer patient-derived organoids.
生成和表征无基质胶前列腺癌患者来源类器官的方案。
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer
通过p300/CBP降解靶向组蛋白H2B乙酰化增强子在前列腺癌中的应用
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
抗糖尿病药物PPARγ激动剂吡格列酮可抑制前列腺癌细胞增殖并诱导代谢重编程。
- 1
- 2
- 3
- 4
- 5
- 6
- 17